Journal
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES
Volume 23, Issue 6, Pages 491-493Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SLE.0b013e31828e3c92
Keywords
venous thrombosis; gastric bypass; laparoscopy
Categories
Funding
- Ministry of Health in Kuwait
Ask authors/readers for more resources
Background:The aim of our study was to determine the therapeutic effect of low-molecular weight heparin after laparoscopic Roux-en-Y gastric bypass.Methods:We prospectively analyzed data of 39 patients who underwent Roux-en-Y gastric bypass from 1093 consecutive patients who underwent bariatric procedures from May 1999 to May 2012. All patients were given 40 mg enoxaparin subcutaneously once daily preoperatively and continued for 5 days.Results:There were 31 females. Mean age was 32.48 years and mean body mass index was 44.59 kg/m(2). Only 46.1% of patients reached the defined therapeutic dose on the second day and 41% on the fifth day. One fatal pulmonary embolism was recorded (1/1093, 0.09%) in the entire series.Conclusions:Anti-Xa surveillance did not correlate strongly with outcome. Further studies are required for proper dose adjustments of low-molecular weight heparin in these obese patients and whether anti-Xa monitoring should be continued.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available